About Autolus Therapeutics plc American Depositary Share
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Market Cap
$0.43B
Employees
647
Listed Since
June 22, 2018
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)